Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Cell ; 163(2): 324-39, 2015 Oct 08.
Article in English | MEDLINE | ID: mdl-26451483

ABSTRACT

Neurodegenerative diseases have been linked to inflammation, but whether altered immunomodulation plays a causative role in neurodegeneration is not clear. We show that lack of cytokine interferon-ß (IFN-ß) signaling causes spontaneous neurodegeneration in the absence of neurodegenerative disease-causing mutant proteins. Mice lacking Ifnb function exhibited motor and cognitive learning impairments with accompanying α-synuclein-containing Lewy bodies in the brain, as well as a reduction in dopaminergic neurons and defective dopamine signaling in the nigrostriatal region. Lack of IFN-ß signaling caused defects in neuronal autophagy prior to α-synucleinopathy, which was associated with accumulation of senescent mitochondria. Recombinant IFN-ß promoted neurite growth and branching, autophagy flux, and α-synuclein degradation in neurons. In addition, lentiviral IFN-ß overexpression prevented dopaminergic neuron loss in a familial Parkinson's disease model. These results indicate a protective role for IFN-ß in neuronal homeostasis and validate Ifnb mutant mice as a model for sporadic Lewy body and Parkinson's disease dementia.


Subject(s)
Interferon-beta/metabolism , Neurons/metabolism , Receptor, Interferon alpha-beta/metabolism , Animals , Autophagy , Disease Models, Animal , Genetic Therapy , Interferon-beta/genetics , Interferon-beta/therapeutic use , Lewy Body Disease/metabolism , Lewy Body Disease/pathology , Mice , Mice, Inbred C57BL , Parkinson Disease/genetics , Parkinson Disease/metabolism , Parkinson Disease/pathology , Parkinson Disease/therapy , Receptor, Interferon alpha-beta/genetics , Signal Transduction , Transcriptome , alpha-Synuclein/metabolism
2.
J Med Case Rep ; 4: 183, 2010 Jun 18.
Article in English | MEDLINE | ID: mdl-20565856

ABSTRACT

INTRODUCTION: New evidence indicates infections are emerging as risk factors for atherosclerosis although their specific role in the development and progression of atherosclerosis is still unclear. CASE PRESENTATION: A 43-year-old Caucasian man who had been treated for four years for multiple sclerosis progressively manifested systemic hypertension, polycythemia, peripheral arterial occlusion with intermittent claudication, and persistent headaches. In 2006, an instrumental analysis (magnetic resonance imaging) of our patient revealed widespread fibrocalcific atherosclerotic lesions which accounted for all his current symptoms, including those related to microbial stimulus. Two particular aspects were of interest, namely a lack of conventional cardiovascular risk factors and a negative family history for cardiovascular events. His chemical blood tests all yielded negative findings although a low positive hepatitis C virus-ribonucleic acid titer was detected. The titer had progressively increased and worsening atherosclerosis threatened the life of our patient. Interferon therapy was not appropriate for our patient due to the severe adverse effects observed shortly after its administration. CONCLUSIONS: The reaction of individual cells to infections may provide an explanation as to why individuals with a similar microbial burden, corrected for the presence of other risk factors, display a different susceptibility to developing or worsening atherosclerosis. The identification of susceptible individuals and the treatment even of silent infections may provide an additional tool against atherosclerosis and its clinical complications. The evaluation of cell susceptibility before and after the correction of risk factors may contribute to the assessment of the efficacy of drug therapy.

3.
J Vasc Res ; 44(4): 253-63, 2007.
Article in English | MEDLINE | ID: mdl-17361089

ABSTRACT

OBJECTIVE: We have previously demonstrated that Mediterranean glucose-6-phosphate dehydrogenase (G6PD)-deficient peripheral blood mononuclear cells (PBMC) respond to mitogenic stimuli with a reduced cholesterol synthesis and growth. In the present study, we have investigated the release of inflammatory molecules by PBMC following a mitogenic stimulus, as well as the transformation to foam cells of monocyte-derived macrophages from severely G6PD-deficient and normal subjects. METHODS AND RESULTS: PBMC from G6PD-deficient subjects produced interleukin (IL)-1beta and IL-6 to a lower extent compared with normal subjects. 5-Hydroxyeicosatetraenoic acid, a primary product of 5-lipoxygenase, was slightly decreased. Tumour necrosis factor-alpha and IL-1beta secretion was significantly reduced in monocyte-derived macrophages. No difference was found in IL-10 secretion, whereas transforming growth factor-beta was invariably found to be significantly higher in G6PD-deficient cells. In cells incubated with acetylated low-density lipoprotein, cholesterol esterification and its storage in lipid droplets were lower than in normal G6PD cells. CONCLUSIONS: We conclude that by reducing the secretion of inflammatory molecules by PBMC and increasing the secretion of transforming growth factor-beta and the capability of monocyte-derived macrophages to accumulate lipid droplets and convert into foam cells, G6PD deficiency may confer a partial protection against atherosclerosis leading to the reduced risk of cardiovascular diseases reported in G6PD-deficient subjects.


Subject(s)
Cytokines/metabolism , Glucosephosphate Dehydrogenase Deficiency/immunology , Glucosephosphate Dehydrogenase Deficiency/metabolism , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Adult , Biomarkers/metabolism , Cells, Cultured , Cholesterol/metabolism , Esterification , Fatty Acids, Unsaturated/metabolism , Foam Cells/cytology , Foam Cells/immunology , Foam Cells/metabolism , Glucosephosphate Dehydrogenase/metabolism , Humans , Hydroxyeicosatetraenoic Acids/metabolism , Leukocytes, Mononuclear/cytology , Macrophages/cytology , Macrophages/immunology , Macrophages/metabolism , Male , Monocytes/cytology , Monocytes/immunology , Monocytes/metabolism , Severity of Illness Index , Thymidine/pharmacokinetics , Tritium
4.
J Hepatol ; 43(3): 485-90, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16023250

ABSTRACT

BACKGROUND/AIMS: We reported massive liver repopulation by transplanted hepatocytes in rats given retrorsine (RS), a pyrrolizidine alkaloid which blocks proliferation of resident cells. In these studies, molecular alterations induced by RS on hepatocyte cell cycle were investigated. METHODS: Animals were treated according to the protocol for liver repopulation, i.e. two injections of RS (30 mg/kg) followed by two-thirds partial hepatectomy (PH) and were sacrificed at various time points thereafter. Livers were analyzed for the expression of cell cycle-related genes. RESULTS: Prior to PH, increased cyclin D1 mRNA and protein levels were found in livers of RS-treated rats. Expression of PCNA was also increased; however, DNA synthesis was not significantly changed. Other cyclins, including cyclin B and cyclin E, were not induced. Cyclin D1 expression increased in controls post-PH and then declined by 48 h, as expected. By contrast, no such modulation of cyclin D1 levels was seen in RS group receiving PH and expression remained high at 48 h, without mitotic division. CONCLUSIONS: Exposure to RS is able to block cell cycle progression after cyclin D1 and PCNA induction, but prior to S phase. Such persistent block outside the resting phase may contribute to the selective replacement of resident cells during liver repopulation.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Cell Cycle/drug effects , Cyclin D1/genetics , Gene Expression Regulation/drug effects , Hepatocytes/physiology , Pyrrolizidine Alkaloids/pharmacology , Animals , Base Sequence , Cyclin B/genetics , DNA Primers , DNA Replication/drug effects , Hepatocytes/drug effects , Male , Protein Biosynthesis , RNA, Messenger/genetics , Rats , Rats, Inbred F344 , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL